Healthcare / Medical Care FacilitiesSES
$0.61
-0.02 (-3.15%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $31.9M · quality 67.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
45/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$582M
P/E
61.5x
↑EV/EBITDA
17.0x
↑ROE
8.9%
↑Gross Margin
87.1%
↑Debt/Equity
1.81
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+2.9%
FCF CAGR
+12.2%
FCF margin
16.2%
FCF / Net income
3.43x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $197.2M · net income $9.3M · FCF $31.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $197.2M | $197.2M | $180.7M | $182.7M | $181.2M |
| Net Income | $9.3M | $9.3M | $14.3M | $11.5M | $11.3M |
| EBITDA | $38.3M | $38.3M | $37.7M | $37.1M | $35.2M |
| EPS | — | — | 0.02 | 0.01 | 0.01 |
| Gross Margin | 87.1% | 87.1% | 88.7% | 88.3% | 86.1% |
| Operating Margin | 11.5% | 11.5% | 13.3% | 12.2% | 13.2% |
| Net Margin | 4.7% | 4.7% | 7.9% | 6.3% | 6.2% |
| Balance Sheet | |||||
| Debt/Equity | 1.81 | 1.81 | 1.09 | 1.31 | 1.46 |
| Current Ratio | 4.75 | 4.75 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $31.9M | $31.9M | $32.0M | $26.7M | $22.6M |
| Returns | |||||
| ROE | 8.9% | 8.9% | 13.5% | 11.6% | 11.7% |
| Valuation | |||||
| P/E | 61.50 | 61.50 | 18.54 | 20.90 | 27.92 |
| EV/EBITDA | 17.01 | 17.01 | 9.18 | 9.10 | 11.81 |
| P/B | 5.56 | 5.56 | 2.51 | 2.44 | 3.27 |
| Growth & Yield | |||||
| Revenue Growth | 9.2% | 9.2% | -1.1% | 0.8% | — |
| EPS Growth | — | — | 23.8% | 1.7% | — |
| Dividend Yield | 1.3% | 1.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+72.1%
Start / end P/E
n/dx → n/dx
EPS bridge
0.02 → n/d
Residual
+70.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.